SBI Securities’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.08K Hold
32
﹤0.01% 2244
2025
Q4
$3.11K Hold
32
﹤0.01% 2222
2025
Q3
$2.28K Sell
32
-140
-81% -$9.33K ﹤0.01% 2372
2025
Q2
$10.3K Buy
172
+1
+0.6% +$55 ﹤0.01% 1693
2025
Q1
$8.97K Buy
171
+3
+2% +$169 ﹤0.01% 1649
2024
Q4
$9.24K Buy
+168
New +$8.84K ﹤0.01% 1681

Other funds holding IRMD

SBI Securities's IRMD Position: Q1 2026 in Review

SBI Securities held its iRadimed (IRMD) position steady in Q1 2026 at 32 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #2244.

SBI Securities first reported a position in IRMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $10.3K in Q2 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • SBI Securities held 32 shares of iRadimed worth $3.08K as of Q1 2026.
  • SBI Securities left its iRadimed share count unchanged in Q1 2026.
  • iRadimed made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2244 holding.
  • SBI Securities first reported a position in iRadimed in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's iRadimed position peaked at $10.3K in Q2 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.